Proposal to list medical devices supplied by Arcomed Limited
Pharmac is seeking feedback on a proposal to list a range of medical devices in Part III of Section H of the Pharmaceutical Schedule.
What we’re proposing
Pharmac is seeking feedback on a proposal to list medical devices supplied by Arcomed Limited (“Arcomed”) in Part III of Section H of the Pharmaceutical Schedule from 1 December 2022 through a non-exclusive provisional agreement.
We propose to list medical devices in the following category:
- Infusion equipment and associated devices (“infusion devices”)
Consultation closes at 4pm Wednesday 12 October 2022 and feedback can be emailed to email@example.com.
What would the effect be?
From 1 December 2022, Arcomed’s range of medical devices in the category noted above would be listed under a national agreement for all Te Whatu Ora hospitals to purchase under, subject to consultation and approval by Pharmac’s Board or delegate (“Agreement”).
The Agreement would not be for sole supply, with Te Whatu Ora hospitals continuing to be able to purchase other suppliers’ brands of Infusion Devices.
The Agreement would supersede any existing Te Whatu Ora contracts with this supplier for the medical devices listed in Schedule 1 in the Agreement. Any device listed in the Pharmac Agreement and purchased by a Te Whatu Ora hospital would be at the price, terms and conditions stated in the Agreement, effective from the date of listing on the Pharmaceutical Schedule.
As part of the Agreement, Arcomed would provide appropriate training and education services that would be tailored to the needs of the individual Te Whatu Ora hospitals, in formats and at times as required by the Te Whatu Ora hospital.
Pricing for the medical devices in the Agreement, subject to any prior termination of the Agreement, would not be increased without prior consultation and approval by Pharmac.
Who we think will be interested
- Te Whatu Ora staff in a range of different clinical settings including but not limited to:
- Clinical Engineers and maintenance services
- Clinical Product Evaluators
- ICU, emergency, and critical care staff
- General medical ward staff
- Nursing assistants
- Perioperative staff
- Procurement Officers and supply chain personnel
- Suppliers and wholesalers
About the medical devices
Infusion devices are medical devices used, or associated with devices used, in the infusion of fluids such as medications, intravenous solutions (such as saline, glucose, and electrolyte solutions), blood, total parenteral nutrition (TPN) solutions into the body. This includes medical devices used in intravenous therapy as well as other infusion therapies.
PHARMAC’s infusion devices category includes:
- non-dedicated and consumable infusion devices not associated with infusion equipment; and
infusion equipment and associated devices.
Why we’re proposing this
In 2018 PHARMAC issued a Request for Proposals (RFP) for:
- supply of infusion devices (including non-dedicated and consumable infusion devices and infusion equipment and associated devices)
The RFP was for non-exclusive national agreements for listing on the Pharmaceutical Schedule.
Pharmac has been working with suppliers to seek provisional agreements and this is the latest proposal to arise from this process. We intend to consult on further provisional agreements with other suppliers of infusion devices over the coming months.
Details about our proposal
Pharmac has entered into a provisional agreement with Arcomed for the supply of infusion devices.
The proposal would result in Pharmaceutical Schedule listings for 281 medical devices as follows:
|Infusion equipment & associated devices
Further information, including pricing and contractual details, has been provided to Te Whatu Ora Procurement personnel. Clinicians interested in further detail on what this change means for their Te Whatu Ora hospital should engage with their Procurement teams.
To provide feedback
Send us an email: firstname.lastname@example.org by 4pm Wednesday 12 October 2022.
All feedback received before the closing date will be considered by PHARMAC’s Board (or its delegate) prior to making a decision on this proposal.
Your feedback may be shared
Feedback we receive is subject to the Official Information Act 1982 (OIA). Please be aware that we may need to share your feedback, including your identity, in response to an OIA request. This applies to anyone providing feedback, whether they are providing feedback themselves or for an organisation, in a personal or professional capacity.
We can only keep feedback confidential as allowed under the OIA and other related laws. If you want any part of your feedback treated as confidential, you need to tell us. Please let us know if you want to keep part of your feedback confidential, and why. Is it commercially sensitive, confidential or proprietary, or personal information? Clearly state this and tell us which parts of your feedback you want to keep confidential for these reasons. We will consider your request under our OIA requirements.